Skip to main content

Table 7 Studies describing hospital costs among patients with resistant and multi-drug resistant A. baumannii

From: Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review

Author

Bacteria

Comparison

Description of cost

Median cost in 2015 USD

Mean cost in 2015 USD

Case

Control

Median cost

Case

Control

Increase

Ratio

P-value

Mean cost

Case

Control

Increase

Ratio

P-value

Cui et al. [98]

A. baumannii

IRAB

ISAB

Total hospital cost

Median (IQR)

16,835(7619–46,479)

7783(3583–36,235)

9052(4035–10,244)

2.16

< 0.01

      

A. baumannii

IRAB

ISAB

Antibiotic cost

Median (IQR)

2558(793–5799)

1257(519–3835)

1301(274–1964)

2.03

< 0.01

      

Zhen et al. [99]

A. baumannii

CRAB

CSAB

Total hospital cost

      

Mean (SD)

30,575(17)

17(11)

10,792(7)

1.55

< 0.000

A. baumannii

CRAB

CSAB

Antibiotic cost

      

Mean (SD)

3047(19)

19(11)

1355(8)

1.80

< 0.000

Lemos et al. [108]

A. baumannii

CRAB

CSAB

Total hospital cost

      

Mean (95%CI)

11,969(10593–13,154)

10,593(6540–8452)

4541(2970–5948)

1.61

< 0.001

A. baumannii

CRAB

CSAB

Antibiotic cost

      

Mean (95%CI)

3854(3234–4383)

3234(2117–3238)

1198(407–1996)

1.45

0.0020

A. baumannii

CRAB

CSAB

Total hospital cost

      

Mean (SD)

12,457(7728)

7728(4150)

4894(3579)

1.65

< 0.001

A. baumannii

CRAB

CSAB

Antibiotic cost

      

Mean (SD)

4316(4242)

4242(2152)

1708(2091)

1.65

0.0020

Lautenbach et al. [100]

A. baumannii

IRAB

ISAB

Hospital charge after culture

     

Mean (95% CI)

393,086(276636–509,536)

276,636(252785–396,002)

68,692(23851–113,533)

1.21

0.0300

Lee et al. [101]

A. baumannii

MDR

Non-MDR

Total hospital cost

      

Mean

15,881

7739

8141

2.05

0.0460

A. baumannii

MDR

Non-MDR

ICU cost

      

Mean

13,933

4311

9622

3.23

0.0020

Wu et al. [102]

A. baumannii

MDR

Non-MDR

Total hospital cost

Median (Q)

24,897(156940)

8823(63540)

16,074(93390)

2.82

< 0.01

      

Guo et al. [103]

A. baumannii

MDR

Non-MDR

Total hospital cost

Median (IQR)

10,452(4742–21,484)

3759(1586–9310)

6693(3156–12,174)

2.78

< 0.001

Mean (SD)

14,087(12302)

12,302(11045)

6638(1257)

1.89

< 0.001

Xu et al. [51]

A. baumannii

MDR

Non-MDR

Total hospital cost

      

Mean (SD)

5446(6481)

6481(3602)

2347(2879)

1.76

0.0250

A. baumannii

MDR

Non-MDR

Antibiotic cost

      

Mean (SD)

222(267)

267(166)

  

0.0540

Lee et al. [104]

A. baumannii

MDR

Non-MDR

Total hospital cost

      

Mean (SD)

12,515(8465)

8465(5375)

6003(3090)

1.92

0.0010

A. baumannii

MDR

Non-MDR

Antibiotic cost

      

Mean (SD)

3021(1822)

1822(1760)

866(62)

1.40

0.0140

Thatrimontrichai et al. [105]

A. baumannii

CRAB

CSAB

Total hospital cost

Median (range)

11,785(2176–45,664)

9745(5266–24,170)

  

> 0.05

      

A. baumannii

CRAB

Without infection

Total hospital cost

Median (range)

11,785(2176–45,664)

7806(3877–33,608)

  

> 0.05

      

Young et al. [106]

A. baumannii

MDR

Without infection

Total hospital charge

      

Mean

372,424

165,032

207,392

2.26

< 0.001

A. baumannii

MDR

Without infection

Total hospital charge

      

Mean

  

73,924

 

< 0.05

Wilson et al. [107]

A. baumannii

MDR

Without infection

Total hospital cost

      

Mean (SD)

269,823(215236)

215,236(156080)

131,961(59155)

1.96

< 0.01

  1. CRAB carbapenem resitance A. baumannii, CSAB carbapenem susceptible A. baumannii, IRAB imipenem resitance A. baumannii, ISAB imipenem susceptible A. baumannii, MDR multi-drug resistance, IQR interquartile range, Q quartile, USD the United States Dollars, SD standard deviation, CI confidence interval